APAC Artificial Skin Market

APAC Artificial Skin Market Size (2023 to 2028)

The artificial skin market in the APAC region is expected to grow at a CAGR of 8.33% from 2023 to 2028.

Y-O-Y growth in the number of burns and accident cases propels the artificial skin market in the Asia-Pacific region. The number of burn cases in India is nearly 7 million per year. The primary factor for these burns is low-level safety, lack of alert in the workplace, and illiteracy in the population. This burn leads to skin damage which requires artificial skin to cover those burns driving the market forward. Females have a high rate of burns compared to males. The higher risk for females is open-fire cooking, unsafe cook stoves, and self-directed or interpersonal violence.

Road accident cases are more in India; some people lead to death, some lose body parts, and some damage their skin. In 2019 a total of 449,002 accidents occurred in India; among them, 451,361 were injured. Road crashes are common in road accidents such as skidding or motorcycle accidents. Some road rashes are cured and take a few weeks to recover, but some cannot be fixed by standard medical assistance. Those people need this artificial skin to be placed on the damaged skin to look normal.

In addition, the growing incidence of chronic wounds is also accelerating the market's growth rate. Chronic wounds are due to diabetes, high cholesterol, cancer, etc. In India number of diabetes patients in 2019 between the age group 20-80 is 74 million. Chronic wounds may be unresponsive to wound care treatments, and skin grafts are used for those wounds. Different bioengineering types can make artificial skin of skin cells. Some use the patient's skin cells, tissue from donated patients, animal tissue cells, or a combination of these.

Furthermore, advanced therapies are used for chronic wounds by using artificial skin substitutes to overcome some of the graft rejection, reduce inflammation, and accelerate the healing process; advancements in artificial skin also drive the market forward. Advanced synthetic skins are developed with features capable of sensing and other factors that act as the same functionalities of natural skin. This is used mainly for skin replacement and burns treatment. In addition, skin regeneration, 3D printing, bioreactors, and electronic skin help to develop various sensory functions, and artificial skin is also used for prosthetic limbs and robots.

On the other hand, allogeneic skin grafts carry a high risk of rejection, and treatment failure is the main factor restraining the market growth. In addition, the high cost of skin treatment, lack of healthcare infrastructure, unawareness among people, and lack of skilled professionals impede the market growth.

This report on the APAC artificial skin market has been segmented and sub-segmented into the following categories.

By Product Type:

• Permanent
• Temporary
• Composite

By Replacement area:

• Dermal
• Epidermal
• Composed

By Material:

• Natural
• Synthetic
• Both

By Application:

• Acute wounds
• Chronic wounds
• Others

By End User:

• Hospitals
• Burn care Centers
• Others

By Country:

• India
• China
• Japan
• South Korea
• Australia
• New Zealand
• Thailand
• Malaysia
• Vietnam
• Philippines
• Indonesia
• Singapore
• Rest of APAC

Geographically, the Asia Pacific is anticipated to have a prominent global market share during the forecast period. In India, the researcher has synthesized Nano fibrous mats and porous sponges using a combination of spider silk protein and silkworm silk protein. This silkworm protein can be used as a skin graft to heal wounds. Most treated wounds with this artificial skin are diabetic foot ulcers. 

In 2022, Japanese scientists at the University of Tokyo developed artificial skin from human skin cells. This acts just like normal skin. It has the touch and feel and can repair itself from minor wounds. This fakes the ability to handle squeezing, twisting, or pushing as well as hot or cold temperatures. This skin is used for humanoid robots for an advanced generation.

China also developed artificial skin that was applied to patients with skin injuries to help heal burns, scalds, and other skin wounds with minimal scarring. This skin is created from living marine material and unique creams.

KEY MARKET PARTICIPANTS:

AVITA Medical, Eucare Pharmaceuticals (P) Ltd., MiMedx, Aroa Biosurgery Limited, Integra LifeSciences, Mallinckrodt Pharmaceuticals, Medskin Suwelack, Misonix, and Organogenesis, Inc. are a few of the noteworthy companies operating in the APAC artificial skin market profiled in this report.